From that Jacob Rowe research note
"This is what the valuation is today, and in three years it could be a much much higher valuation depending on how the team executes on both QLE and ASPI we could see valuations go well above $8b with each entity having possibly valuations of $3b+ (QLE) and $5b+ (ASPI)."
So this guy is talking US8b valuation v US500m today before the Renergen deal is added to ASPI ?
Renergen alone at US300m ebitda per year with a x 20 multiple could be worth US6b by itself also I guess. Or higher longer term if ebitda outperforms to US500m + for instance.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.020(1.85%) |
Mkt cap ! $33.35M | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.10 | $1.05 | $125.2K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2235 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 22202 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| RLT (ASX) Chart |